William Blair Initiates Coverage of Foundation Medicine with Market Perform Rating | GenomeWeb

NEW YORK (GenomeWeb News) – Investment bank William Blair on Thursday initiated coverage of Foundation Medicine with a Market Perform rating.

In a report, analyst Amanda Murphy noted Foundation's differentiated platform, an untapped clinical market, and the company's pharmaceutical business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.